Chronic medication use may increase in breast cancer survivors after cancer treatment
the ONA take:
Researchers report an increase in breast cancer survivor’s use of chronic medication after cancer treatment. The study was published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers sought to characterize the patterns of medication use by survivors of early-stage breast cancer from diagnosis to 1 year after chemotherapy.
Researchers enrolled 107 patients diagnosed between December 2011 and June 2014, all participants were treated at a single center. Medication use data was retrieved from prescription databases and records from the National Electronic Health Records.
Results showed that 46.7% of participants developed non-cancer comorbidities, including hypertension, hyperlipidemia, and diabetes.
The most common chronic medication types before chemotherapy were calcium channel blockers and lipid-modifying agents. Their use persisted during and after chemotherapy. The most commonly used post-chemotherapy medication was hormonal therapy.
Researchers found that there was a statistically significant increase in the average number of chronic disease medication classes prescribed to patients between the pre-chemotherapy and chemotherapy periods, as well as between the chemotherapy and post-chemotherapy periods (P < 0.0001).
“This study provides important insights into the design of medication management programs tailored to this population. Future studies should incorporate a control population to improve the interpretation of study results,” the authors concluded.
Researchers report an increase in breast cancer survivor’s use of chronic medication after cancer treatment.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|